
Cornea and External Disease
Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient
The first patient in the United States has been dosed in a Phase 3 clinical trial evaluating cenegermin-bkbj ophthalmic solution for the...
Cornea specialists identify key clinical signs linked to microbial keratitis subtypes
United States cornea specialists identified a limited set of clinical features they believe reliably distinguish microbial keratitis (MK) organism groups, according to...
Preventing complications of superficial keratectomy
The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or...
Latest Cornea and External Disease Videos
Medication practices after DMEK surgery vary widely across Europe due to lack of standard guidelines
Medication practices following Descemet Membrane Endothelial Keratoplasty (DMEK) surgery vary widely across Europe due to a lack of standardized guidelines, with most surgeons relying on local protocols or personal experience...
Study compares two crosslinking approaches for progressive keratoconus
Both progressive keratoconus treated with either transepithelial phototherapeutic keratectomy (PTK) and topography-guided photorefractive keratectomy (TG-PRK) are safe and effective for treating progressive keratoconus, but TG-PRK-CXL offers greater visual improvement, more...
Learn about a drop to treat acute infectious conjunctivitis
In a new episode of The Ophthalmic Project, Mark Dlugoss speaks with Joshua Moriarty, CEO of Okogen, to discuss a new product in development for infectious conjunctivitis. Mark Dlugoss: Healthcare...
Findings support AC paracentesis as a frontline tool in uveitis workup
Anterior chamber paracentesis is a safe and valuable diagnostic tool for identifying infectious causes of uveitis, with a pathogen detection rate of about 25% and a low complication rate. The...
Corneal recovery time after contact lens use varies by lens type
The time needed for the cornea to return to its natural shape after stopping contact lens use varies widely depending on the lens type and individual factors, according to a...
Ocubio launches qualified autologous serum eye drops
Alfonso L. Sabater, MD, PhD, of the Bascom Palmer Eye Institute, spoke with Ophthalmology 360 at the American Society of Cataract and Refractive Surgery Annual Meeting about the launch of...
Who is the ideal candidate for EVO ICL?
Neda Nikpoor, MD, an ophthalmologist at Jenkins Eye Care in Honolulu, Hawaii, spoke with Ophthalmology 360 about her experience using EVO ICL and who the ideal patient is for this...